PARIS, September 26 /PRNewswire/ --
- State-of-the-art medical training center in Paris designed to advance standard of patient care
Boston Scientific Corporation (NYSE: BSX) today announced the grand opening of the International Institute for Therapy Advancement in Paris. The Institute is dedicated to providing world-class training and education to help healthcare professionals advance the standard of patient care. The 3,000 square-meter facility offers the latest in modern medical training and current clinical science focused on cardiac and vascular therapies. The grand opening, hosted by Boston Scientific senior executives, was attended by leading European electrophysiologists.
"The pace of innovation and the volume of clinical data make it difficult for healthcare professionals to master new procedures and focus on essential advancements in their field," said Professor Panos E. Vardas, Cardiology Department, University Hospital of Heraklion in Crete, Greece and President-Elect of the European Heart Rhythm Association. "The Institute for Therapy Advancement recognizes this challenge and is committed to helping physicians develop the latest skills and techniques that can impact clinical practice and create immediate value for patients and the healthcare community."
"The Institute is an exceptional facility in its simulation and teaching capabilities," said David McFaul, Boston Scientific Senior Vice President, International. "Combined with our staff's impressive expertise, we are able to provide physicians with valuable training in current cardiac and vascular therapies."
The Institute offers in-depth training that combines practical skills development with the latest evidence-based clinical science. Physicians benefit from state-of-the-art equipment, fully functional catheterization labs, virtual reality simulators and modern classrooms with satellite capacity for live case observation. Clinical programs are designed and taught by independent physician experts and respected opinion leaders who ensure the scientific quality of teaching content. As a result, most Institute programs have received accreditation from authorized CME boards across Europe. Current courses are offered in Cardiac Rhythm Management and Heart Failure Management with new courses beginning in 2009 covering Interventional Cardiology and Peripheral Interventions.
"Our new facility will allow us to continue the principles and core values that have made the Institute for Therapy Advancement the leading innovator in medical education," said Philippe Champaud, Director of The Institute for Therapy Advancement. "The Paris Institute is a reflection of our commitment to helping physicians learn the most relevant developments in their field and put them into daily clinical practice."
The Institute for Therapy Advancement in Paris will host hundreds of healthcare professionals annually and is part of Boston Scientific's global medical education network with campuses in St. Paul, Minnesota, Tokyo, and Myasaki, Japan.
For more information, please visit
www.therapy-advancement.com.Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit:
www.bostonscientific.com.Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. The Company wishes to caution the reader that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with clinical trials, the regulatory approval process, physician acceptance of new products, competitive product offerings, intellectual property, litigation, and other factors described in the Company's filings with the Securities and Exchange Commission.
CONTACT: Paul Donovan +1-508-650-8541 (office) +1-508-667-5165 (mobile) Media Relations Boston Scientific Corporation Larry Neumann +1-508-650-8696 (office) Investor Relations Boston Scientific Corporation
Web site:
http://www.bostonscientific.comPaul Donovan, Media Relations, +1-508-650-8541 (office), +1-508-667-5165 (mobile), or Larry Neumann, Investor Relations, +1-508-650-8696 (office), both of Boston Scientific Corporation
Copyright: 2010 PR Newswire Europe. All rights to PR Newswire Content are owned by PR Newswire Association LLC and/or its Affiliates or used under l
icence from their licensors. Any copying or other use of PR Newswire Content including without limitation by caching, framing, linking or otherwise is expressly forbidden
without the prior written consent of PR Newswire Europe Limited or an appropriate Affiliate.
ADVERTISING